clinical trial · NCT06779071
Pivotal Clinical Trial to Evaluate the Efficacy and Safety After NPNP-001 Application in Patients with Knee Osteoarthritis.
PharmaResearch Co.,Ltd·phase3·enrolling by invitation·n = 260
Knee OsteoarthritisNPNP-001Conjuran
brief summary
This study was designed to demonstrate non-inferiority and safety in pain reduction after NPNP-001 application in patients with knee osteoarthritis.
started
Jan 8, 2025
primary completion
May 1, 2025
completion
Jun 1, 2026
last updated
Jan 20, 2025
official title
A Multicenter, Randomized, Double-blinded, Active-controlled, Non-inferiority, Pivotal Clinical Trial to Evaluate the Efficacy and Safety in Pain Reduction After NPNP-001 Application in the Knee Joint of Patients with Knee Osteoarthritis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol